Shockwave Medical Inc. (NASDAQ:SWAV)

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?

Shockwave Medical Inc., effective income tax rate (EITR) reconciliation

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
	Statutory federal income tax rate	21.00%	21.00%	21.00%	21.00%	21.00%
	Effective tax rate	73.78%	-375.00%	-16.22%	-0.58%	-0.58%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

The analysis of income tax rates reveals a significant divergence between the statutory federal income tax rate and the effective tax rate over the five-year period ending December 31, 2023.

Statutory Tax Rate Stability: The statutory federal income tax rate remained constant at 21.00% throughout the entire observed period, establishing a consistent baseline for tax calculations.
Negative Effective Tax Rate Trend (2019–2022): Between 2019 and 2022, the effective tax rate remained consistently negative, indicating a trend where tax benefits or credits offset taxable income. The rate was stable at -0.58% in 2019 and 2020, followed by a decline to -16.22% in 2021. This trend culminated in a severe outlier in 2022, where the effective tax rate dropped to -375.00%.
Effective Tax Rate Reversal (2023): A dramatic shift occurred in 2023, as the effective tax rate transitioned from a deeply negative position to a positive 73.78%. This result not only marks a reversal of the previous four-year trend but also significantly exceeds the 21.00% statutory rate, suggesting the influence of substantial tax adjustments or a change in the company's underlying profitability and tax asset valuation.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?

Shockwave Medical Inc., components of deferred tax assets and liabilities

US$ in thousands

	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net operating loss carryovers	60,636)	60,467)	85,764)	73,453)	49,862)
Fixed and intangible assets	—)	—)	512)	718)	450)
Accruals and reserves	12,856)	10,876)	7,603)	2,245)	1,619)
Stock-based compensation	8,745)	8,504)	5,523)	2,060)	780)
Research and development credits	20,736)	15,250)	4,698)	3,379)	2,336)
Contributions	—)	—)	42)	42)	20)
Lease liability	9,816)	9,316)	7,398)	2,004)	2,135)
Capitalized research and development	34,511)	17,791)	—)	—)	—)
Convertible note	22,841)	—)	—)	—)	—)
Other	92)	—)	—)	—)	—)
Deferred tax assets	170,233)	122,204)	111,540)	83,901)	57,202)
Valuation allowance	(57,848)	(13,371)	(104,773)	(82,087)	(55,085)
Gross deferred tax assets	112,385)	108,833)	6,767)	1,814)	2,117)
Fixed and intangible assets	(5,624)	(1,105)	—)	—)	—)
Right-of-use-assets	(7,592)	(8,327)	(6,767)	(1,814)	(2,117)
In process research and development	(3,609)	—)	—)	—)	—)
Other	—)	(1,833)	—)	—)	—)
Gross deferred tax liabilities	(16,825)	(11,265)	(6,767)	(1,814)	(2,117)
Net deferred tax assets (liabilities)	95,560)	97,568)	—)	—)	—)

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

A significant expansion in deferred tax assets is observed between 2019 and 2023, with gross deferred tax assets increasing from 57.2 million USD to 170.2 million USD. This growth is primarily driven by a diversification of the asset components and a substantial increase in specific tax-related credits and capitalizations.

Primary Drivers of Deferred Tax Assets: Net operating loss carryovers represented the largest component of deferred tax assets through 2021, peaking at 85.8 million USD before stabilizing at 60.6 million USD by 2023. Concurrently, research and development credits showed aggressive growth, rising from 2.3 million USD in 2019 to 20.7 million USD in 2023. Other notable increases occurred in accruals and reserves, which grew from 1.6 million USD to 12.9 million USD, and stock-based compensation, which increased from 780 thousand USD to 8.7 million USD over the same period.
Recent Asset Emergence: The composition of deferred tax assets shifted in the later years of the analysis. Capitalized research and development emerged as a significant factor in 2022 at 17.8 million USD, nearly doubling to 34.5 million USD by 2023. Additionally, a convertible note contribution of 22.8 million USD was recorded in 2023, further inflating the gross asset balance.
Deferred Tax Liabilities Trends: Gross deferred tax liabilities exhibited a steady upward trend, increasing from 2.1 million USD in 2019 to 16.8 million USD in 2023. This growth was largely attributed to right-of-use assets and the emergence of liabilities related to fixed and intangible assets, which reached 5.6 million USD by 2023.
Valuation Allowance and Net Position: The valuation allowance remained high from 2019 to 2021, nearly offsetting the gross deferred tax assets. A sharp reduction in the valuation allowance occurred in 2022, dropping to 13.4 million USD, which indicates an increased probability of realizing these tax benefits. Although the allowance increased to 57.8 million USD in 2023, the company maintained a strong net deferred tax asset position of 95.6 million USD, compared to a negligible net position in the early years of the period analyzed.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?

Shockwave Medical Inc., deferred tax assets and liabilities, classification

US$ in thousands

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
	Deferred tax assets	99,169)	97,568)	—)	—)	—)
	Deferred tax liabilities	3,609)	—)	—)	—)	—)

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

The reporting of deferred tax items is observed only for the 2022 and 2023 fiscal years, with no figures recorded for the period between 2019 and 2021. The financial position regarding deferred taxes is characterized by a substantial asset balance that slightly increased over the last two reported years.

Deferred Tax Assets: A marginal increase in deferred tax assets is observed, rising from 97,568 thousand US dollars in 2022 to 99,169 thousand US dollars in 2023. This upward trend indicates a continued accumulation of temporary differences or tax credits that may be used to reduce future taxable income.
Deferred Tax Liabilities: Deferred tax liabilities were absent in 2022 but emerged in 2023 with a value of 3,609 thousand US dollars. The introduction of this liability suggests the creation of new temporary differences where tax payments are deferred to future periods.
Net Deferred Tax Position: The net deferred tax position remains strongly skewed toward assets. While the emergence of liabilities in 2023 slightly offsets the asset balance, the net asset position remains significant, indicating a favorable future tax outlook based on the recorded temporary differences.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?

Shockwave Medical Inc., Financial Data: Reported vs. Adjusted

Shockwave Medical Inc., adjustments to financial statements

US$ in thousands

	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Adjustment to Total Assets
Total assets (as reported)	1,566,563)	646,089)	345,682)	272,042)	231,938)
Less: Noncurrent deferred tax assets, net	99,169)	97,568)	—)	—)	—)
Total assets (adjusted)	1,467,394)	548,521)	345,682)	272,042)	231,938)
Adjustment to Total Liabilities
Total liabilities (as reported)	897,886)	134,773)	103,852)	46,388)	39,285)
Less: Noncurrent deferred tax liabilities, net	3,609)	—)	—)	—)	—)
Total liabilities (adjusted)	894,277)	134,773)	103,852)	46,388)	39,285)
Adjustment to Stockholders’ Equity
Stockholders’ equity (as reported)	668,677)	511,316)	241,830)	225,654)	192,653)
Less: Net deferred tax assets (liabilities)	95,560)	97,568)	—)	—)	—)
Stockholders’ equity (adjusted)	573,117)	413,748)	241,830)	225,654)	192,653)
Adjustment to Net Income (loss)
Net income (loss) (as reported)	147,278)	215,996)	(9,136)	(65,699)	(51,109)
Add: Deferred income tax expense (benefit)	14,708)	(97,276)	—)	—)	—)
Net income (loss) (adjusted)	161,986)	118,720)	(9,136)	(65,699)	(51,109)

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

A comparative analysis of reported and adjusted financial figures reveals a significant divergence beginning in the 2022 fiscal year, specifically concerning the treatment of deferred taxes. While figures remained identical from 2019 through 2021, the subsequent years demonstrate a systematic removal of tax-related items to arrive at adjusted valuations for assets, equity, and net income.

Balance Sheet Adjustments: A consistent disparity is observed between reported and adjusted total assets starting in 2022. In 2022, reported assets of 646.1 million US$ were adjusted downward to 548.5 million US$, representing a reduction of approximately 97.6 million US$. This trend continued into 2023, where reported assets of 1.57 billion US$ were adjusted to 1.47 billion US$, a difference of approximately 99.2 million US$. These adjustments are mirrored in the stockholders' equity, which was reduced by 97.6 million US$ in 2022 and 95.6 million US$ in 2023, indicating the removal of deferred tax assets from the equity calculation.
Income Statement Divergence: The impact of tax adjustments on net income is pronounced and variable. In 2022, reported net income of 216.0 million US$ was adjusted downward to 118.7 million US$, suggesting that a substantial non-cash tax benefit inflated the reported result. Conversely, in 2023, the reported net income of 147.3 million US$ was adjusted upward to 162.0 million US$, indicating that the reported figure was reduced by tax expenses that were excluded from the adjusted performance metric.
Liability and Growth Trends: Total liabilities remained aligned between reported and adjusted figures until 2023, where a marginal adjustment of 3.6 million US$ occurred. On a broader scale, the organization experienced exponential growth in reported total assets, increasing from 231.9 million US$ in 2019 to 1.57 billion US$ by 2023. A significant increase in reported total liabilities is also noted in 2023, rising to 897.9 million US$ from 134.8 million US$ in the prior year, which coincides with the period of most aggressive asset expansion.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?

Shockwave Medical Inc., Financial Ratios: Reported vs. Adjusted

Shockwave Medical Inc., adjusted financial ratios

	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Profit Margin
Reported net profit margin	20.17%	44.10%	-3.85%	-96.92%	-119.06%
Adjusted net profit margin	22.18%	24.24%	-3.85%	-96.92%	-119.06%
Total Asset Turnover
Reported total asset turnover	0.47	0.76	0.69	0.25	0.19
Adjusted total asset turnover	0.50	0.89	0.69	0.25	0.19
Financial Leverage
Reported financial leverage	2.34	1.26	1.43	1.21	1.20
Adjusted financial leverage	2.56	1.33	1.43	1.21	1.20
Return on Equity (ROE)
Reported ROE	22.03%	42.24%	-3.78%	-29.11%	-26.53%
Adjusted ROE	28.26%	28.69%	-3.78%	-29.11%	-26.53%
Return on Assets (ROA)
Reported ROA	9.40%	33.43%	-2.64%	-24.15%	-22.04%
Adjusted ROA	11.04%	21.64%	-2.64%	-24.15%	-22.04%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Financial performance analysis reveals a significant transition from substantial operational losses to consistent profitability between 2019 and 2023. From 2019 through 2021, no variance is observed between reported and adjusted ratios, indicating that deferred tax impacts were negligible during the initial loss-making period. Starting in 2022, a clear divergence emerges, demonstrating that deferred tax accounting began to materially influence reported financial metrics.

Profitability and Return Metrics: The net profit margin shifted from a deficit of -119.06% in 2019 to a positive reported margin of 20.17% by 2023. While the reported margin peaked in 2022 at 44.10%, the adjusted margin remained more conservative at 24.24% in 2022 and 22.18% in 2023. A similar pattern is evident in Return on Equity (ROE) and Return on Assets (ROA). In 2022, reported ROE (42.24%) and ROA (33.43%) were significantly higher than their adjusted counterparts (28.69% and 21.64%, respectively). By 2023, this trend reversed, with adjusted ROE (28.26%) and adjusted ROA (11.04%) exceeding the reported figures of 22.03% and 9.40%.
Operational Efficiency and Leverage: Total asset turnover increased from 2019, reaching a peak in 2022. The adjusted total asset turnover consistently exceeded the reported ratio from 2022 onward, recording 0.89 against 0.76 in 2022 and 0.50 against 0.47 in 2023. Financial leverage showed a marked increase in 2023, rising to a reported 2.34. The adjusted financial leverage was higher at 2.56, suggesting that the removal of deferred tax items reduces the equity base, thereby amplifying the leverage ratio.
Impact of Deferred Tax Adjustments: The divergence between reported and adjusted figures highlights the volatility introduced by deferred tax accounting. The substantial inflation of reported profitability in 2022 relative to adjusted figures suggests the recognition of deferred tax assets or a significant one-time tax benefit. In contrast, the 2023 results show adjusted metrics surpassing reported metrics, indicating that reported net income was suppressed by current tax expenses or the amortization of deferred tax assets.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?

	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
As Reported
Selected Financial Data (US$ in thousands)
Net income (loss)	147,278)	215,996)	(9,136)	(65,699)	(51,109)
Revenue	730,230)	489,733)	237,146)	67,789)	42,927)
Profitability Ratio
Net profit margin¹	20.17%	44.10%	-3.85%	-96.92%	-119.06%
Adjusted for Deferred Taxes
Selected Financial Data (US$ in thousands)
Adjusted net income (loss)	161,986)	118,720)	(9,136)	(65,699)	(51,109)
Revenue	730,230)	489,733)	237,146)	67,789)	42,927)
Profitability Ratio
Adjusted net profit margin²	22.18%	24.24%	-3.85%	-96.92%	-119.06%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

2023 Calculations

¹ Net profit margin = 100 × Net income (loss) ÷ Revenue
= 100 × 147,278 ÷ 730,230 = 20.17%

² Adjusted net profit margin = 100 × Adjusted net income (loss) ÷ Revenue
= 100 × 161,986 ÷ 730,230 = 22.18%

A significant financial transition is observed between 2019 and 2023, as the company moved from substantial net losses to consistent profitability. The period from 2019 to 2021 was marked by negative margins, though a steady recovery trend began in 2020, culminating in a pivot to positive earnings in 2022.

Profitability Trajectory: The adjusted net profit margin demonstrated a sharp upward trajectory, rising from -119.06% in 2019 to 22.18% by 2023. The most critical inflection point occurred between 2021 and 2022, where the margin shifted from a near-breakeven -3.85% to a robust 24.24%, signaling a fundamental change in the company's earning capacity.
Reported versus Adjusted Performance: From 2019 through 2021, reported and adjusted net income and profit margins were identical, suggesting an absence of significant non-recurring items during those years. However, a divergence emerged in 2022, where reported net income (US$ 215,996 thousand) significantly exceeded adjusted net income (US$ 118,720 thousand). This resulted in a reported profit margin of 44.10%, nearly double the adjusted margin of 24.24%, indicating the impact of one-time gains or tax benefits.
Margin Stabilization and Divergence in 2023: In 2023, the relationship between reported and adjusted figures inverted. Adjusted net income increased to US$ 161,986 thousand, while reported net income decreased to US$ 147,278 thousand. This caused the reported net profit margin to drop to 20.17%, while the adjusted net profit margin remained relatively stable at 22.18%. The stability of the adjusted margin suggests that the core operational profitability has leveled off, whereas the reported figures continue to be influenced by non-operational fluctuations.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?

	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
As Reported
Selected Financial Data (US$ in thousands)
Revenue	730,230)	489,733)	237,146)	67,789)	42,927)
Total assets	1,566,563)	646,089)	345,682)	272,042)	231,938)
Activity Ratio
Total asset turnover¹	0.47	0.76	0.69	0.25	0.19
Adjusted for Deferred Taxes
Selected Financial Data (US$ in thousands)
Revenue	730,230)	489,733)	237,146)	67,789)	42,927)
Adjusted total assets	1,467,394)	548,521)	345,682)	272,042)	231,938)
Activity Ratio
Adjusted total asset turnover²	0.50	0.89	0.69	0.25	0.19

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

2023 Calculations

¹ Total asset turnover = Revenue ÷ Total assets
= 730,230 ÷ 1,566,563 = 0.47

² Adjusted total asset turnover = Revenue ÷ Adjusted total assets
= 730,230 ÷ 1,467,394 = 0.50

The company experienced a period of substantial asset expansion and fluctuating operational efficiency between 2019 and 2023, characterized by a peak in asset utilization in 2022 followed by a decline in 2023.

Total Asset Expansion: Reported total assets grew consistently from US$ 231.9 million in 2019 to US$ 1.57 billion by the end of 2023. The growth accelerated significantly after 2021, with the asset base more than doubling between 2021 and 2022, and further increasing by approximately 142% in 2023.
Asset Turnover Trends: The reported total asset turnover ratio demonstrated a strong upward trend from 2019 to 2022, rising from 0.19 to 0.76. This indicates an increasing ability to generate revenue per unit of asset. However, a reversal occurred in 2023, with the ratio dropping to 0.47, suggesting that the rapid increase in assets during that year exceeded the corresponding growth in revenue.
Impact of Asset Adjustments: While reported and adjusted figures were identical from 2019 through 2021, a divergence appeared in 2022 and 2023. Adjusted total assets were lower than reported assets in these final two years, which resulted in a higher adjusted total asset turnover. Specifically, in 2022, the adjusted turnover reached 0.89 compared to the reported 0.76, and in 2023, the adjusted turnover remained slightly higher at 0.50 compared to the reported 0.47.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?

	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
As Reported
Selected Financial Data (US$ in thousands)
Total assets	1,566,563)	646,089)	345,682)	272,042)	231,938)
Stockholders’ equity	668,677)	511,316)	241,830)	225,654)	192,653)
Solvency Ratio
Financial leverage¹	2.34	1.26	1.43	1.21	1.20
Adjusted for Deferred Taxes
Selected Financial Data (US$ in thousands)
Adjusted total assets	1,467,394)	548,521)	345,682)	272,042)	231,938)
Adjusted stockholders’ equity	573,117)	413,748)	241,830)	225,654)	192,653)
Solvency Ratio
Adjusted financial leverage²	2.56	1.33	1.43	1.21	1.20

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

2023 Calculations

¹ Financial leverage = Total assets ÷ Stockholders’ equity
= 1,566,563 ÷ 668,677 = 2.34

² Adjusted financial leverage = Adjusted total assets ÷ Adjusted stockholders’ equity
= 1,467,394 ÷ 573,117 = 2.56

An analysis of the financial position between 2019 and 2023 reveals a period of aggressive asset expansion and a subsequent shift in the capital structure. Total assets grew from 231.9 million USD in 2019 to 1.57 billion USD by the end of 2023, representing a substantial increase in the organizational resource base.

Asset and Equity Expansion: Reported total assets showed a steady increase through 2021, followed by an accelerated trajectory in 2022 and 2023. While stockholders' equity also grew, rising from 192.7 million USD in 2019 to 668.7 million USD in 2023, the pace of asset growth significantly outstripped the growth in equity during the final two years of the period.
Financial Leverage Trends: The reported financial leverage ratio remained relatively stable, fluctuating between 1.20 and 1.43 from 2019 to 2022. However, a sharp increase occurred in 2023, with the ratio rising to 2.34. This indicates a higher reliance on liabilities to fund asset growth in the most recent fiscal year.
Adjusted Financial Leverage Analysis: Adjusted figures were identical to reported figures from 2019 through 2021. A divergence emerged in 2022 and intensified in 2023, where adjusted financial leverage reached 2.56, exceeding the reported leverage of 2.34. This suggests that after adjusting for specific financial items, the leverage position is more elevated than reported, reflecting a more aggressive financial structure in the latter stages of the period analyzed.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?

	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
As Reported
Selected Financial Data (US$ in thousands)
Net income (loss)	147,278)	215,996)	(9,136)	(65,699)	(51,109)
Stockholders’ equity	668,677)	511,316)	241,830)	225,654)	192,653)
Profitability Ratio
ROE¹	22.03%	42.24%	-3.78%	-29.11%	-26.53%
Adjusted for Deferred Taxes
Selected Financial Data (US$ in thousands)
Adjusted net income (loss)	161,986)	118,720)	(9,136)	(65,699)	(51,109)
Adjusted stockholders’ equity	573,117)	413,748)	241,830)	225,654)	192,653)
Profitability Ratio
Adjusted ROE²	28.26%	28.69%	-3.78%	-29.11%	-26.53%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

2023 Calculations

¹ ROE = 100 × Net income (loss) ÷ Stockholders’ equity
= 100 × 147,278 ÷ 668,677 = 22.03%

² Adjusted ROE = 100 × Adjusted net income (loss) ÷ Adjusted stockholders’ equity
= 100 × 161,986 ÷ 573,117 = 28.26%

The financial trajectory from 2019 to 2023 is characterized by a transition from consistent operational losses to sustained profitability, accompanied by a significant expansion of the equity base.

Net Income Performance: Reported and adjusted net losses were observed from 2019 through 2021, with the deficit peaking in 2020 at 65.699 million US dollars. A pivot to profitability occurred in 2022, where reported net income reached 215.996 million US dollars. By 2023, a divergence emerged between reported and adjusted figures; reported net income declined to 147.278 million US dollars, while adjusted net income increased to 161.986 million US dollars, suggesting the impact of non-recurring items or tax-related adjustments.
Stockholders' Equity Growth: Equity experienced steady growth, rising from 192.653 million US dollars in 2019 to 668.677 million US dollars in 2023. A notable acceleration in equity accumulation is evident between 2021 and 2022. Beginning in 2022, a gap appeared between reported and adjusted equity, with adjusted equity remaining consistently lower than reported levels, ending at 573.117 million US dollars in 2023.
Return on Equity (ROE) Analysis: ROE transitioned from deeply negative values in 2019 (-26.53%) and 2020 (-29.11%) to positive territory in 2022. In 2022, reported ROE peaked at 42.24%, significantly higher than the adjusted ROE of 28.69%. By 2023, this relationship inverted; reported ROE fell to 22.03%, while adjusted ROE remained stable at 28.26%. This indicates that while reported performance fluctuated, the adjusted metric reflects a more consistent capacity to generate returns on adjusted equity during the profitable period.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?

	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
As Reported
Selected Financial Data (US$ in thousands)
Net income (loss)	147,278)	215,996)	(9,136)	(65,699)	(51,109)
Total assets	1,566,563)	646,089)	345,682)	272,042)	231,938)
Profitability Ratio
ROA¹	9.40%	33.43%	-2.64%	-24.15%	-22.04%
Adjusted for Deferred Taxes
Selected Financial Data (US$ in thousands)
Adjusted net income (loss)	161,986)	118,720)	(9,136)	(65,699)	(51,109)
Adjusted total assets	1,467,394)	548,521)	345,682)	272,042)	231,938)
Profitability Ratio
Adjusted ROA²	11.04%	21.64%	-2.64%	-24.15%	-22.04%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

2023 Calculations

¹ ROA = 100 × Net income (loss) ÷ Total assets
= 100 × 147,278 ÷ 1,566,563 = 9.40%

² Adjusted ROA = 100 × Adjusted net income (loss) ÷ Adjusted total assets
= 100 × 161,986 ÷ 1,467,394 = 11.04%

The financial trajectory from 2019 to 2023 demonstrates a transition from early-stage losses to sustained profitability, accompanied by an aggressive expansion of the asset base.

Net Income and Profitability Trends: A significant shift in profitability is observed beginning in 2022. Reported net income moved from a loss of 51,109 thousand USD in 2019 to a profit of 147,278 thousand USD by 2023. The adjusted net income shows a more consistent upward trend in the final two years, increasing from 118,720 thousand USD in 2022 to 161,986 thousand USD in 2023, indicating strong underlying operational growth.
Asset Base Expansion: Total assets experienced substantial growth over the five-year period. Reported total assets rose from 231,938 thousand USD in 2019 to 1,566,563 thousand USD in 2023. The most pronounced acceleration occurred between 2022 and 2023, where the asset base more than doubled, suggesting significant investment or acquisition activity.
Return on Assets (ROA) Dynamics: The Return on Assets followed a volatile path, moving from deep negatives in 2019 and 2020 to a peak in 2022. Reported ROA reached a high of 33.43% in 2022 before declining to 9.40% in 2023. Adjusted ROA followed a similar pattern, peaking at 21.64% in 2022 and moderating to 11.04% in 2023. This decline in the final year is primarily attributed to the rapid expansion of total assets, which outpaced the growth in net income, thereby diluting the ROA.
Comparison of Reported vs. Adjusted Metrics: A divergence between reported and adjusted figures became apparent in 2022 and 2023. In 2023, the adjusted ROA of 11.04% outperformed the reported ROA of 9.40%. This indicates that certain non-recurring or reporting-specific items negatively impacted the reported net income relative to the adjusted operational performance.

AI Ask an analyst for more